vip outfit

PicoCELA Files for 2M Share IPO at $4-$6/sh

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" Thanks for your interest in Kalkine Media's content! To continue reading, please log in to your account or create your free account with us.

Glucosamine Hydrochloride Market Expands as Demand for Joint Health Supplements Rises 11-27-2024 08:28 PM CET | Advertising, Media Consulting, Marketing Research Press release from: Data Bridge Market Research Private Ltd . / PR Agency: Data Bridge Market Research Private Ltd . Glucosamine Hydrochloride Market Expands as Demand for Joint Health Supplements Rises "Global Glucosamine Hydrochloride Market, By Product Type (Powder, Liquid), Grade (Greater Than or Equal To 98%, Greater Than or Equal To 99%), Application (Health Food, Medicine, Others) - Industry Trends and Forecast to 2031. Data Bridge Market Research analyses that the global glucosamine hydrochloride market was valued at USD 178.60 million in 2023 is expected to reach the value of USD 274.10 million by 2031, at a CAGR of 5.50% during the forecast period of 2024 to 2031. Explore Further Details about This Research Glucosamine Hydrochloride Market Share Report https://www.databridgemarketresearch.com/reports/global-glucosamine-hydrochloride-market **Segments** - By Form: Powder, Liquid - By End-Use: Pharmaceuticals, Supplements, Animal Feed Glucosamine hydrochloride is a key ingredient in products aimed at supporting joint health and mobility, making it a vital component in the pharmaceutical, supplements, and animal feed industries. In terms of form, the glucosamine hydrochloride market is segmented into powder and liquid forms. The powder form is preferred for its ease of incorporation into various products, while the liquid form offers more flexible application options. When considering end-use segments, pharmaceuticals utilize glucosamine hydrochloride in drugs aimed at treating joint conditions, supplements incorporate it to support overall joint health, and animal feed manufacturers use it to enhance the joint health of livestock and pets. **Market Players** - Bioiberica - Cargill, Incorporated - Koyo Chemical Co., Ltd. - Panvo Organics Pvt. Ltd. - Dalian Angtai Pharmaceutical Co., Ltd. - Golden-Shell Pharmaceutical Co., Ltd. The global glucosamine hydrochloride market is highly competitive, with key players constantly striving to innovate and expand their product offerings. Bioiberica, a prominent player in the market, is known for its high-quality glucosamine hydrochloride products aimed at various industry segments. Cargill, Incorporated is another major player with a strong presence in the market, offering a diverse range of glucosamine hydrochloride solutions. Other notable market players include Koyo Chemical Co., Ltd., Panvo Organics Pvt. Ltd., Dalian Angtai Pharmaceutical Co., Ltd., and Golden-Shell Pharmaceutical Co., Ltd., all of which contribute significantly to the market's growth and development. The global market for glucosamine hydrochloride is witnessing significant growth due to increasing awareness about joint health and mobility issues across various demographics. The demand for pharmaceuticals, supplements, and animal feed products containing glucosamine hydrochloride is on the rise, driving the market's expansion. The segmenting of the market based on the form of the product, such as powder and liquid, provides versatility for manufacturers and consumers alike. The powder form offers convenience in product formulation, while the liquid form provides flexibility in application methods, catering to different industry requirements. Market players in the glucosamine hydrochloride sector are engaged in fierce competition, focusing on product innovation, quality enhancements, and diversified offerings to maintain a competitive edge. Companies like Bioiberica and Cargill, Incorporated are at the forefront, leveraging their expertise to deliver high-quality glucosamine hydrochloride products to meet the varying needs of pharmaceutical, supplement, and animal feed industries. These key players' continuous efforts in research and development contribute significantly to the market's growth trajectory, ensuring a steady supply of innovative solutions to address joint health concerns. The market dynamics of the glucosamine hydrochloride sector are influenced by factors such as changing consumer preferences, regulatory frameworks, and technological advancements in product development. As consumers become more health-conscious and proactive in managing joint-related issues, the demand for glucosamine hydrochloride products is likely to increase. Moreover, the pharmaceutical industry's focus on developing advanced treatments for joint conditions further drives the market's growth, creating opportunities for market players to expand their product portfolios and reach a wider consumer base. In conclusion, the global market for glucosamine hydrochloride presents promising prospects for industry players, driven by the growing emphasis on joint health and mobility worldwide. With innovation, research, and strategic partnerships, market players can capitalize on emerging trends and consumer demands to solidify their positions in this competitive landscape. As the market continues to evolve, collaborations and investments in product development will be crucial**Market Players** Cargill, Incorporated (U.S.) Panvo Organics Pvt Ltd. (India) Koyo Chemical Industry Co., Ltd. (Japan) Qingdao Jiulong Biopharmaceutical Co., Ltd. (China) 3A PHARMA (Qatar) Golden-Shell Pharmaceutical (China) The global market for glucosamine hydrochloride is displaying robust growth, primarily fueled by the increasing awareness about joint health and mobility concerns across diverse demographics. The escalating demand for pharmaceuticals, supplements, and animal feed products containing glucosamine hydrochloride is propelling market expansion. Segmenting the market based on product form, such as powder and liquid, offers versatility to manufacturers and consumers, with powder providing convenience in formulation and liquid allowing for flexible application methods to meet industry requirements. Market players in the glucosamine hydrochloride industry are engaged in intense competition, focusing on innovation, quality improvements, and diversification of offerings to stay competitive in the market landscape. Key companies like Bioiberica and Cargill, Incorporated are leading the way by leveraging their expertise to deliver top-notch glucosamine hydrochloride products tailored to the varied needs of pharmaceutical, supplement, and animal feed sectors. The continual research and development efforts of these major players significantly contribute to the market's growth trajectory, ensuring a constant supply of innovative solutions to address joint health issues. The dynamics of the glucosamine hydrochloride market are shaped by factors such as evolving consumer preferences Table Of Content 1 Introduction 1.1 Objectives Of The Study 1.2 Glucosamine Hydrochloride Market Definition 1.3 Overview 1.4 Limitations 1.5 Markets Covered 2 Glucosamine Hydrochloride Market Segmentation 2.1 Glucosamine Hydrochloride Market Covered 2.2 Geographical Scope 2.3 Years Considered For The Study 2.4 Currency And Pricing 2.5 Dbmr Tripod Data Validation Model 2.6 Multivariate Modeling 2.7 Primary Interviews With Key Opinion Leaders 2.8 Dbmr Glucosamine Hydrochloride Market Position Grid 2.9 Dbmr Vendor Share Analysis 2.1 Secondary Sources 2.11 Assumptions 3 Executive Summary............. Browse Related Reports: https://payalnath852.blogspot.com/2024/11/mint-and-menthol-market-growing.html https://payalnath852.blogspot.com/2024/11/mobile-cardiac-telemetry-monitors_27.html https://payalnath852.blogspot.com/2024/11/mushroom-drinks-market-growing-demand.html https://payalnath852.blogspot.com/2024/11/precision-agriculture-market.html Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India Data Bridge Market Research is a market research and consulting company that educates its clients about the market and encourages growth and expansion. We offer customized reports, syndicated research, consulting services, cloud-connected intelligence, and a holistic suite of offerings including competitive intelligence, epidemiology analyses, trade analytics, country analysis, and pharma insights. We deliver objective and actionable insights, crafted to meet the unique needs of our clients. Our database features thousands of statistics and in-depth analyses on 200 plus industries and more than 5000 markets in 75 major countries globally. Additionally, DBMR has served for more than 40% of Fortune 500 firms internationally and has a more than 3000 client's network. This release was published on openPR.SAINT CHARLES, Mo. (AP) — Jaylon McDaniel's 22 points helped Lindenwood defeat IU Indianapolis 81-63 on Saturday night. McDaniel shot 9 of 12 from the field and 4 of 6 from the free-throw line for the Lions (5-6). Markeith Browning II scored 18 points while going 8 of 19 (1 for 3 from 3-point range) and added seven rebounds, five assists, and three steals. Reggie Bass shot 3 for 6 (2 for 5 from 3-point range) and 6 of 7 from the free-throw line to finish with 14 points, while adding seven rebounds and six assists. Paul Zilinskas finished with 18 points for the Jaguars (5-8). IU Indianapolis also got 13 points and two steals from Jarvis Walker. Alec Millender also recorded 11 points and five assists. NEXT UP Lindenwood's next game is Thursday against Tennessee Tech at home, and IU Indianapolis visits Florida International on Saturday. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .

Science fiction is easily one of the most popular and prolific genres in movies today. But while there are countless major hit sci-fi movies, there's many if not even more cult sci-fi classics still waiting to be discovered. Sci-fi cinema began almost as soon as movies themselves began, with Georges Méliès' A Trip to the Moon – widely considered the first sci-fi movie – released in 1902. Méliès was only the first of more than a century of filmmakers using science fiction to contemplate humanity's future – the dreams, the nightmares, the endless possibilities. While there's a ton of undisputed classics in the genre, there're many more underrated and undiscovered gems that still deserve their proper due. For those worn out on Terminator and Avatar, for those who've had their fill of Star Wars and Star Treks to last a lifetime yet still crave the speculative tech and outlandish tales of extraterrestrial existence – congratulations, you've come to the right place. This is your new favorite go-to list of under-the-radar science fiction flicks. Here are 32 underrated sci-fi movies. 32. I'm Your Man (2021) Can love be created? Even programmed? That's the question powering Emma Braslavsky's acclaimed science fiction romance I'm Your Man, released in 2021. Dan Stevens (The Guest, FX's Legion) stars as Tom, an android who is designed to be the perfect partner exclusively for lonely scientist Alma (Maren Eggert). As part of a research project, Alma is forced to live with Tom and document their relationship. While Alma is resistant at first, emotions slowly become real. Sparks really fly in this alluring German-language production, a movie that supposes love can be found when you least expect it. 31. The Super Inframan (1975) The genre of transforming superheroes like Ultraman, Kamen Rider, and Power Rangers began in Japan. But in 1975, prolific Hong Kong studio Shaw Brothers took a stab at their own metamorphing hero with The Super Inframan, from director Hua Shan. Danny Lee stars as the red-clad lightning avenger, Inframan, who saves the Earth from alien invaders using his new superpowers and mastery of kung fu. While Chinese action movies are typically either lavish Wuxia historical epics or bombastic "heroic bloodshed" dramas, The Super Inframan stands out as a cross-cultural hybrid of many influences. It's a movie still deserving of the franchise treatment, even now. Fun fact: Ant-Man director Peyton Reed confirmed in a 2018 Q&A on Twitter/X that the MCU's Ant-Man was visually inspired by The Super Inframan. 30. I.S.S. (2023) In this overlooked pressure cooker thriller, Russian and American astronauts aboard the International Space Station grow suspicious of one another when a ground war between the superpowers begins back on Earth. Thanks to a small but capable cast, including Ariana DeBose, Chris Messina, and John Gallagher Jr., I.S.S. powers through its shortcomings to be a suspenseful story about trust, and if hatred really is as simple as picking sides. Also, for a tiny budget of less than $14 million, I.S.S. has some pretty spectacular production value with gorgeous overviews of Earth. 29. The Pod Generation (2023) Writer/director Sophie Barthes satirizes our very possible future in her sci-fi rom-com The Pod Generation. Emilia Clarke (of Game of Thrones fame) and Chiwitel Ejiofor co-star as a married couple living in a near future New York City. In trying to start a family, Clarke's character Rachel is eager to give birth via mobile artificial wombs, while Alvy (Ejiofor) is hoping for more traditional methods. The Pod Generation is terrifically funny, with quietly dark underpinnings of our imminent submission to artificial intelligence and technology. Because when we even depend on the machines to give birth, at what point are we still human? The Pod Generation lightly ponders this question with delightful humor. 28. Radius (2017) This low budget Canadian sci-fi thriller features abundant touches of apocalyptic and disease horror, resulting in a compelling but understated gem. In Radius, Diego Klattenhoff and Charlotte Sullivan play amnesiac survivors of a car accident who slowly realize they each have a strange physical effect. Klattenhoff's Liam seems capable of passively killing everyone around him, while the woman, Jane Doe (Sullivan) can cancel out that effect. Complete with a striking twist ending, Radius is not one to keep away from. 27. After Yang (2021) After drawing acclaim for his deeply human drama Columbus in 2017, writer/director Koganda lent his sensibilities to the realm of sci-fi with his equally adored movie After Yang. Colin Farrell and Jodie-Turner Smith play members of a family living in the future as they attempt to repair Yang, their "adopted" android son who was purchased on the second-hand market. In doing so, they discover Yang's secret desires to be human. Replete with themes of grief, loss, memory, and impermanence, Koganda's affecting After Yang brings remarkable warmth to a genre too often concerned with the steely exteriors of a cynical future. 26. Oblivion (2013) In 2022, Tom Cruise and Joseph Kosinski teamed up for the billion-dollar smash Top Gun: Maverick, a legacy sequel that tore up the skies. But their collaboration started almost a decade earlier with the nearly forgotten sci-fi actioner Oblivion. Set in the future, after Earth is devastated following a nuclear war between humans and aliens, a repairman (Cruise) and his communications officer (Andrea Riseborough) find they are not the only ones left on the planet. This slowly begins a journey into realizing exactly what happened that destroyed the planet. Oblivion drew only mixed reviews from critics but did well enough at the box office. While it's far from Cruise's best movie, it might surprise anyone curious enough to see it for themselves. 25. Fingernails (2023) If science fiction movies too often conjure images of stark white suits and impossible technologies, let Chirstos Nikou's emotionally charged Fingernails – released on Apple TV+ in 2023 – help you alter your assumptions. In this delicate drama, a young woman named Anna (Jessice Buckley) begins working at The Love Institute, a start-up company that practices a popular new test that unquestionably proves if your partner is your soulmate. Though Anna and her partner Ryan (Jeremy Allen White) already enjoy a positive result, Anna's work at The Love Institute puts her in close proximity with Amir (Riz Ahmed), which has Anna questioning everything. While Fingernails is indeed sci-fi, its grounded, even analog setting affords it relatable authenticity. 24. Sputnik (2020) While its plot summary reads like a Russian-language remake of Ridley Scott's Alien, Sputnik succeeds through the strength of its solid direction by Egor Abramenko, its lead actress Oksana Akinshina, and an emotional last-minute twist ending. Set in the waning years of the Cold War, Sputnik follows a doctor (Akinshina) who is brought on to assess the only living cosmonaut to survive an accident in space who brings back an alien organism in his body. Besides Andrei Tarkovsky's 1972 Soviet classic Solaris, there are few worthwhile Russian sci-fi films of note. But Sputnik makes a case for itself, revealing there is still plenty of territory to explore in the worn-out sci-fi/horror genre. 23. Making Mr. Right (1987) It's as scientifically sophisticated as an Atari video game, but Making Mr. Right has its gears in the right places. In this retro sci-fi rom-com from Susan Seidelman, lively bachelorette Frankie (Ann Magnuson) is hired by an eccentric scientist (John Malkovich) to interact with an advanced android replica of himself before it's shipped off for a deep space mission. The goal is to make the android come off as human – or at least, human enough – to appease sponsors and politicians. But of course, sparks unexpectedly start to fly. Feeling like a mixture of other '80s classics like Weird Science and The Mannequin, Making Mr. Right offers its own charms thanks to a very playful Malkovich. 22. No One Will Save You (2023) A minimalist sci-fi horror about surviving challenges in isolation, No One Will Save You follows a lonely young woman (Kaitlyn Dever) – who is strangely shunned by her neighbors – whose home is invaded one night by aliens and mind-controlling parasites. Proving that actions speak louder than words, No One Will Save You balances out its few lines of dialogue with propulsive, breathless action. While it sounds like War of the Worlds meets The Strangers on paper, No One Will Save You is assuredly singular through its work by writer/director Brian Duffeld. 21. Dreamscape (1984) An overlooked sci-fi action-horror from the 1980s, Dreamscape plunges into the world of dreams to eventually rescue the U.S. President. Far predating movies like Inception and Olympus Has Fallen, Dreamscape stars Dennis Quaid as a psychic recruited to participate in an experimental study by his former mentor (played by Max von Sydow). The study: Breaking the laws of physics to enter someone's dreams. While Dreamscape gets lost in its own sauce and struggles to figure out what movie it really wants to be, it's a good '80s romp that will satisfy genre aficionados and '80s obsessives who've already seen The Terminator and Back to the Future too many times to count. 20. Vesper (2022) A science fiction movie centered around ecology and biohacking, Vesper stars Raffiella Chapman as a young teenaged girl who lives in a ravaged future Earth where most of humanity struggles just to eat. Chapman, as the titular heroine Vesper, figures a way to access the bacteria in the seeds to make them fertile once more, which is key to mankind's survival. But she must first survive the ruthlessness of her uncle (Eddie Marsan) and the comfortable oligarchy who subjugate everyone else. Vesper is understated and often gorgeous, being about perseverance and brilliance meant for the good of all. 19. Save Yourselves! (2020) Co-written and co-directed by Alex Huston Fischer and Eleanor Wilson, Save Yourselves! stars John Reynolds and Sunita Mani as Brooklynites who commit to actually unplugging from their oblivion machines – their phones – and enjoy the outdoors. During a stay at a remote AirBnB with no cellular service, the outside world is suddenly overtaken by aliens. Alien invasions collide with millennial malaise in this affable comedy, with its modernized take on genre classics like The Day the Earth Stood Still and War of the Worlds, plus a nod to Star Trek's Tribbles for good measure. Save Yourselves! proves there's virtue in getting away from it all. 18. Altered States (1980) A psychedelic sci-fi thriller that descends into mania, Altered States stars William Hurt as an academic psychopathologist conducting research in sensory deprivation and hallucinogenic substances. During the course of the long study, Hurt's character becomes a family man (with Blair Brown as his wife and later ex-wife), only to become dangerously obsessive about it when he unlocks a frightening breakthrough. Directed by Ken Russell and adapted from screenwriter Paddy Chayefsky's own 1978 novel, Altered States is mind-melting goodness and deserves to be better recognized alongside the greats of the genre. 17. Event Horizon (1997) Set in the year 2047, Event Horizon follows a group of astronauts on a rescue mission to investigate a once-missing spaceship that has just returned near Neptune. A moody sci-fi horror in the spirit of Alien, the movie floats thanks in part to its strong ensemble cast, including Laurence Fishburne, Sam Neil, Jason Isaacs, Joely Richaradson, Kathleen Quinlan, and Sean Pertwee. While Event Horizon has cultivated its reputation as a cult classic over a long period of time, it's still got some ways to go before it officially enters orbit as a legitimate genre masterpiece instead of the overlooked gem it remains. 16. Archive (2020) In this impressive sci-fi thriller by writer/director Gavin Rothery, Theo James plays Jules, a scientist on a time-sensitive mission to develop the most advanced artificial intelligence. Secretly, however, Jules is working to create a way to bring back his deceased wife (Stacy Martin). Its slated premiere at SXSW in 2020 was canceled due to the COVID-19 pandemic, which made its release on VOD and streaming a quiet affair, but Archive was sort of the perfect movie for quarantine given its focus on obsession in isolation. Without that unintended context, however, Archive is a strong sci-fi movie on its own with very handsome production design. 15. Prospect (2018) Just before he donned the armored suit of The Mandalorian, Pedro Pascal co-starred in the sleeper hit indie sci-fi Prospect. The movie primarily follows Cee (played by Sophie Thatcher), a teenage girl who travels to space with her father (Jay Duplass) to mine a forest moon for precious stones only to encounter treachery along the way. Pascal appears as Ezra, a rival prospector whose role as the antagonist is aided by his snake-like vibe. While there's impressive effects and compelling worldbuilding in Prospect, the movie succeeds on the strengths of its characters and how it gets by on its modest limitations as a micro-budget sci-fi. 14. Redline (2009) I don't care how much anime you might have seen: Redline is truly unlike anything you've experienced before. A cross between Mad Max and Speed Racer, this psychedelic sci-fi anime that runs purely on vibes takes place in the future, where the biggest spectacle is the ultra-deadly planetary racing tournament Redline. Pompadoured superstar JP (voiced by Takuya Kimura) is one of the most popular racers in Redline and grows determined to win it all after a huge setback from a mafia boss. Marking the directorial debut of animator Takeshi Koike, Redline is one of the gnarliest gems in the Madhouse library, sharing lineage with other anime classics like Wicked City, Ninja Scroll, Perfect Blue, and Tokyo Godfathers. 13. Possessor (2020) While it initially seemed Brandon Cronenberg was intent to follow his father's David Cronenberg's footsteps, it soon became apparent that the younger Cronenberg is his own singular artist in Possessor. In Brandon Cronenberg's striking sci-fi horror movie, an assassin (Andrea Riseborough) carries out her assignments by scientifically possessing the bodies of other people. But her latest job has her fighting from within when her new body's host fights back. Provocative, alluring, and thick with grime, Possessor paralyzes the senses to leave you in shock – and awe. 12. Underwater (2020) Kristen Stewart fights for air in this maddeningly overlooked sci-fi monster flick that was unceremoniously dumped in theaters in early 2020. In Underwater, a group of scientists – played by Stewart, Vincent Cassel, Jessica Henwick, John Gallagher Jr., TJ Miller, and more – find their lives endangered when their deep sea research facility gets damaged due to unexpectedly violent underwater earthquakes. Minor spoilers: It's not a natural phenomenon that's causing the earthquakes. Fans of H.P. Lovecraft's mythos better dive in for Underwater, a better-than-you-expect piece of science fiction and horror from director William Eubank. 11. The Island (2005) Just before taking on the mega-hit Transformers series, Michael Bay let loose this summer crowd-pleaser that offers up Bay's own excessive spin on dystopian science fiction. Ewan McGregor and Scarlett Johansson co-star as residents of an underground community who believe Earth has fallen due to environmental apocalypse; they live highly organized and routine lives, with the promise of maybe winning the lottery to go to a lush tropical island forever. But not all is what it seems. While genre fans will find nods to everything from Logan's Run to THX 1138 to even Soylent Green, The Island is solid dumb fun that benefits from Bay's usual bombast. 10. Come True (2020) Inspired by his own bouts of sleep paralysis, writer/director Anthony Scott Burns explores the darkness of sleep in his 2020 sci-fi horror Come True. The movie follows a teenage runaway, Sarah (Julia Sarah Stone) who joins a university's sleep study just to have some food and a safe place to crash. But Sarah's refuge suddenly becomes a literal nightmare as the tests leave Sarah vulnerable to recurring encounters with an evil presence. A 2020s feature that oozes 1980s horror vibes, Come True is powerful enough to leave you tossing and turning at night. 9. LFO (2013) A sci-fi thriller that is at times outrageously funny, this Swedish-language indie hails from director Antonio Tublén and explores how the need for control can lead to losing it entirely. LFO follows an ordinary if pathetic man, Robert (Patrik Karlson) who suspects his wife is cheating on him. One day, Robert stumbles upon a radio frequency that allows him to hypnotize and control anyone who hears it. His experiments with the frequency dangerously escalate into Robert controlling everyone around him, which is fun at first but naturally includes horrific (but hilarious) consequences. Unusual but quirky, LFO goes up to 11 – and then breaks the dial. 8. Gatchaman (2013) Before Power Rangers, there was Gatchaman. A live-action modern reboot of the classic anime Science Ninja Team Gatchaman – better known in the United States as Battle of the Planets, and later G-Force – Gatchaman essentially tells the origin story of the winged superheroes, formed by the International Science Organization. While the movie doesn't live up to the majesty of the classic anime, which was laced with themes of conversation and ethical use of technology, it's still a kick-butt science fiction superhero movie that is underrated and overlooked even by hardcore tokusatsu faithful. Step aside, Avengers – let these forerunner heroes take flight. 7. Upgrade (2018) Leigh Whannell's sci-fi thriller Upgrade is about a man who yields to a dangerous alter ego – with very, very deadly results. Upgrade stars Logan Marshall-Green as Grey, a mechanic who becomes paralyzed after a group of men shoot him and kill his wife (Melanie Vallejo). Implanted with a cutting-edge computer chip, Grey is able to walk again. But the chip's scary A.I. has its own motivations, and offers Grey the opportunity to get his sweet revenge in exchange for letting the A.I. use his body. Deliriously and deliciously violent, Upgrade is like a cross between John Wick, Venom, and Ex Machina, but Whannell's sharp direction makes it its own thing. 6. Synchronic (2019) Synchronic, which has a totally unique take on time travel, also has Anthony Mackie in maybe his single-best performance of his career. Mackie co-stars with Jamie Dornan, playing two best friends and paramedics in New Orleans who encounter a new designer drug on the streets, called Synchronic. While Synchronic has funky effects for adults, for kids, it has a different result entirely: briefly time traveling to the past. When Dornan's character Dennis finds his daughter is missing after taking Synchronic, Mackie's Steve races against time – and his own illness – to use the drug and locate her before she's gone forever. While most critics were disappointed by Synchronic as an underwhelming entry by genre masters Justin Benson and Aaron Moorhead, the movie still gets props for its original premise and uniquely dark atmosphere that makes time travel scarier than you could imagine. 5. Midnight Special (2016) In 2016, you could find Michael Shannon in two movies: Batman v Superman: Dawn of Justice, where his corpse as Zod is desecrated to create the monstrosity Doomsday, and Jeff Nichols' incredible Midnight Special. In Nichols' film, Shannon plays a father on the lam with his precious son (Jaeden Lieberher), who exhibits unbelievable superpowers and is thus hunted by religious fanatics and the federal government. Also starring Joel Edgerton, Kirsten Dunst, and Adam Driver, Midnight Special is a very human look at impossible miracles, making it a highly original sci-fi that feels like an Amblin adventure movie that's all grown up. 4. Alive (2002) Genre enthusiasts should know Ryuhei Kitamura. After the underground success of his zombie action thriller Versus, Kitamura spent the 2000s directing similarly dark action thrillers before finding more mainstream success. In 2002, Kitamura helmed Alive, based on the manga by Tsutomu Takahashi. After a death row inmate (Hideo Sakaki) survives his first punishment, he is forced to take part in a science experiment that pits him in an isolated cell with another prisoner and a violent alien organism. While Kitamura has better movies in his body of work, Alive is an excellent demonstration of a transgressive director going buckwild in confined spaces. 3. Aniara (2018) After climate change ravages Earth, humanity whisks away to Mars in luxury spaceships. But one ship full of colonists veers off course, leaving the colonists to deal with the absolute uncertainty of their future. One character, a nameless employee (Emelie Garbers) becomes overwhelmed when her simulation machine of Earth's verdant past becomes overused by the desperate passengers. Directed by Pella Kågerman and based on Harry Martinson's 1956 poem, Aniara is a movie about collective regret, a film that reveals our eagerness to do anything but actually fix what's wrong. 2. The Vast of Night (2019) The Vast of Night's flavor of vintage sci-fi is so good yet so fresh, you might listen to some Elvis right afterward. Fittingly released into drive-in theaters in May 2020, Andrew Patterson's The Vast of Night takes audiences back to New Mexico, circa 1950s, following a radio deejay (Jake Horowitz) and a switchboard operator (Sierra McCormick) who receive a mysterious signal coming from some- thing in space. A beautiful mixture of War of the Worlds and American Graffiti, The Vast of Night overcomes its low-budget limits to deliver a truly suspenseful experience. 1. Ad Astra (2019) You would think a sci-fi movie starring Brad Pitt would be a bigger deal. But for some reason, audiences are still discovering Ad Astra. From James Gray, the movie stars Pitt as an astronaut who ventures to space to locate his once-presumed dead father (Tommy Lee Jones), himself a heroic astronaut, after his space station near Neptune is deemed to be the source of dangerous power surges which threaten life on Earth. While Ad Astra is a gorgeous story about identity, unfinished business, and the fallacy of hero worship, it also has some truly dazzling set-pieces, including a shoot-out rover chase on the Moon. Ad Astra is an emotionally driven sci-fi classic still waiting to be discovered.Health officials urging vaccination as whooping cough, pneumonia cases spike

James Carville rips young ‘snot-nosed’ progressive staffers for hurting Harris campaign with ‘hissy fit’ over Joe Rogan: ‘Huge f–king error’

OCALA, Fla.--(BUSINESS WIRE)--Nov 27, 2024-- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued the following statement refuting the false and misleading claims recently made by a group of activist investors (collectively, the “Activist Group”) relating to their multi-year attempt to take over AIM’s Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”), presently scheduled for December 17, 2024. Since 2016, the Board and management team have worked to overcome multiple obstacles, refocus the Company’s clinical development programs to high-value indications, improve its financial condition and lay the foundation for long-term shareholder value creation. To be clear, the Board and management are unhappy with the Company’s stock price performance – but they are doing everything possible to continue the significant momentum with Ampligen – which is ultimately what will create long-term value for all shareholders. Unfortunately, the Activist Group has accused AIM of lying about its historical share price. by claiming in its proxy statement: The truth is that AIM’s stock has never traded anywhere near such a price: Consider the following instances where its members have been found by the Delaware Court of Chancery (the “Court”) to have lied to or misled shareholders: Furthermore, the Court confirmed “ ” 10 by pursuing litigation against AIM. The Delaware Court of Chancery agreed with the Board in both 2022 and 2023. Following the Activist Group’s appeal, the Supreme Court of Delaware upheld the Court’s decision in favor of AIM earlier this year – . : AIM encourages shareholders to vote “ ” ALL four of the Board’s incumbent candidates – , , and – in connection with the Annual Meeting, on the universal proxy card. For more information on how to vote, visit: . *** AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen ® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. For more information, please visit and connect with the Company on , , and . This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “continue,” “believe,” “potential,” “upcoming” and other variations thereon and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Many of these forward-looking statements involve a number of risks and uncertainties. Data, pre-clinical success and clinical success seen to date does not guarantee that Ampligen will be approved as a treatment or therapy for any diseases or conditions. The Company urges investors to consider specifically the various risk factors identified in its most recent Annual Report on Form 10-K, and any risk factors or cautionary statements included in any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K, filed with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the PSLRA. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. The Company, its directors and executive officers, Peter W. Rodino, III and Robert Dickey, IV, are deemed to be “participants” (as defined in Section 14(a) of the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company’s stockholders in connection with the Annual Meeting. The Company filed its definitive proxy statement (the “Definitive Proxy Statement”) and a universal proxy card with the SEC on November 4, 2024 in connection with such solicitation of proxies from the Company’s stockholders. The Definitive Proxy Statement contains information regarding the identity of the participants, and their direct and indirect interests, by security holdings or otherwise, in the Company’s securities and can be found in the section titled “Principal Stockholders” of the Definitive Proxy Statement and available . Information regarding subsequent changes to their holdings of the Company’s securities can be found in the SEC filings on Forms 3, 4, and 5, which are available on the Company’s website available or through the SEC’s website at . Stockholders will be able to obtain the Definitive Proxy Statement, any amendments or supplements thereto and other documents filed by the Company with the SEC at no charge at the SEC’s website at . Copies will also be available at no charge at the Company’s website at . ______________________________ 1 The Activist Group’s . 2 the March 2016 , filed with the SEC on March 16, 2016 (emphasis added). 3 ; the . 4 (emphasis added). 5 December 28, 2023, Opinion of the Delaware Court of Chancery: (emphasis added). 6 (emphasis added). 7 (emphasis added). 8 (emphasis added). 9 , 2022 WL 16543834, at *32 (Del. Ch. Oct. 28, 2022). (emphasis added). 10 December 28, 2023, Opinion of the Delaware Court of Chancery: (emphasis added). 11 July 29, 2024, Order on Motion for Reargument of the Delaware Supreme Court. View source version on : CONTACT: Investor Contact: JTC Team, LLC Jenene Thomas 908-824-0775 Media Contact: Longacre Square Partners Joe Germani / Miller Winston KEYWORD: FLORIDA DELAWARE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY INFECTIOUS DISEASES HEALTH PHARMACEUTICAL ONCOLOGY SOURCE: AIM ImmunoTech Inc. Copyright Business Wire 2024. PUB: 11/27/2024 03:30 PM/DISC: 11/27/2024 03:29 PM

HAL to start trial of new Tejas fighter jet in January next yearThe “College Report” is back and will appear on a more regular basis moving forward. Today’s column will focus on football, sprint football and volleyball from the fall sports season. The next column will include a list of all known commitments/signings made by current high school students and recaps of the remaining fall sports (golf, soccer, tennis, cross country). Winter sports will be recapped in late December or early January. Among the most decorated fall athletes in football, sprint football and volleyball are: • St. Mary-of-the-Woods had five sprint football players to receive all-Midwest Sprint Football League honors. Former Riverton Parke standout running back Derron Hazzard was named to the first-team offensive squad after rushing for 605 yards and 10 touchdowns as a sophomore. Named to the first-team defense were Parke Heritage grad Austin Petrillo, a junior defensive back who had three interceptions and ranked third on the team in tackles. The other players honored are Sullivan grads — linebacker Joshua Wence on the first team (led team with 52 tackles) and second-team choices Lane Sluder (junior defensive lineman) and Kyle Vernelson (junior wide receiver). Also honored was Terre Haute South grad Courtney Jones, a junior at Lipscomb University who was named to the all-ASUN Conference first team. She was a third-team all-ASUN choice last year. Jones led her team in kills and had 17 games with double-figure kill totals for the second straight year. • South Vermillion grad Augustus Shryock was a second-team all-Heartland Collegiate Athletic Conference choice on the defensive line. • Linton grad Gentry Warrick, a junior at Miami (Ohio), had a solo block in a loss to Northern Illinois this season to tie her for 10th all time in school history with 54 solo blocks. A few other notes that popped up during player research: • Terre Haute North and Indiana State graduate Steve Englehart is slowly turning around the Presbyterian College football program. The Blue Hose were just 1-10 in his first year, but improved to 4-7 last year and finished 6-6 this year. The team’s backup quarterback this year is redshirt sophomore Ty Englehart, son of the head coach who completed 20 of 39 passes for 263 yards and three touchdowns in four games of action. In high school, Englehart set the single-season touchdown record at Holy Trinity Episcopal Academy and earned offensive player of the year honors. He is majoring in Pre-Allied Health Sciences at Presbyterian. • Sullivan grad Lucas Copenhaver redshirted at the University of Indianapolis last year and entered his name in the transfer portal. Copenhaver, a 6-2, 290-pound interior offensive lineman, bucked the trend of players needing to go down a level or two to find a new place to play. Copenhaver landed with Division I Marshall. The Thundering Herd is 8-3 with one game left against James Madison this weekend, and will play in a bowl game later this year. Copenhaver has not seen a lot of action yet, but is one to keep an eye on with his size and strength. See lists of fall athletes and coaches with Wabash Valley connections online at www.tribstar.com . Joey Bennett can be reached at jbblkc@gmail.com . Please send any additions or corrections to him at this email address.

President-elect Donald Trump weighed in on the mysterious drone incidents happening in parts of the country in a short post to Truth Social on Friday evening. "Mystery Drone sightings all over the Country," wrote Trump. "Can this really be happening without our government’s knowledge. I don’t think so! Let the public know, and now. Otherwise, shoot them down!!!" ALSO READ: A dark mystery from America's past could save us from Trump's tyranny The drones, whose purpose is unknown, were first identified flying around New Jersey , alarming local officials and residents alike. Some witnesses have said the drones are the size of cars and are in prime position to spy on people's property . Trump is not the first public official to comment on the matter. New Jersey Gov. Phil Murphy has assured people the matter is under investigation , and Rep. Marjorie Taylor Greene (R-GA) burst out in a fury over the incident. "I'm going to call it total bulls--- that no one knows what these are," she posted. "They can track down a guy that just killed a CEO, but they can't identify what nightly drones are and where they're coming from."

Winners of Kanpur Youth Fest awardedBy Arathy Somasekhar (Reuters) -Oil prices were little changed on Wednesday, pressured by a large surprise build in U.S. gasoline stocks and worries about U.S. interest rate cuts next year, but prices drew support from concerns about supply eased after a ceasefire deal between Israel and Hezbollah. Brent crude futures settled 2 cents higher at $72.83 a barrel. U.S. West Texas Intermediate crude slipped 5 cents to $68.72. U.S. gasoline stocks rose by 3.3 million barrels in the week to 212.2 million barrels, the Energy Information Administration said, counter to analysts’ expectations in a Reuters poll for a draw of 46,000 barrels.​ Crude stocks fell by 1.8 million barrels in the week ended Nov. 22, the EIA added, far exceeding analysts’ expectations in a Reuters poll for a draw of 605,000 barrels. Market sources, citing the American Petroleum Institute, had said on Tuesday that oil inventories fell by 5.94 million barrels and fuel inventories rose last week. “It is surprising to see gasoline inventories building so much and implied demand not really budging week-on-week, given expected record travel this Thanksgiving,” said Matt Smith, an analyst at Kpler. Oil prices also were dented by U.S. data showing progress on lowering inflation appears to have stalled in recent months, which could narrow the scope for the Federal Reserve to cut interest rates in 2025. Traders added to bets the U.S. central bank will lower borrowing costs by 25 basis points at its Dec. 17-18 meeting, according to CME Group’s FedWatch tool. However, they anticipate the Fed will leave rates unchanged at its meetings in January and March. Slower-than-expected rate cuts would keep the cost of borrowing elevated, which could slow economic activity and dampen demand for oil. Both oil benchmarks settled lower on Tuesday after Israel agreed to a ceasefire deal with Lebanon’s Hezbollah group, effective Wednesday after both sides accepted the agreement brokered by the U.S. and France. The ceasefire started on Wednesday. “The real question will be for how long it (the ceasefire) will truly be honoured,” said Dennis Kissler, senior vice president of trading at BOK Financial. Oil gained support after sources from the OPEC+ group, which includes the Organization of the Petroleum Exporting Countries and allies led by Russia, said it is discussing a further delay to the oil output increase set for January. The group, which produces about half of the world’s oil, had aimed to gradually ease production cuts through 2024 and 2025, but weaker global demand and rising output outside OPEC+ have cast doubt on that plan. The decision will be made at a Dec. 1 meeting. The heads of commodities research at Goldman Sachs and Morgan Stanley said oil prices are undervalued, citing a market deficit and risk to Iranian supply from possible sanctions when U.S. President-elect Donald Trump takes office. Sources also told Reuters on Tuesday that crude oil would not be exempt from the 25% tariffs that Trump has threatened to impose on all products coming into the U.S. from Mexico and Canada. Oil industry analysts and traders warned the move would likely raise oil prices for U.S. refiners, squeezing margins and driving up the cost of fuel. (Reporting by Arunima Kumar in Bengaluru, Yuka Obayashi in Tokyo and Emily Chow in Singapore; editing by David Goodman, Jason Neely, Jonathan Oatis, David Gregorio and Paul Simao) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );monsitj Investment Thesis Illinois Tool Works Inc. ( NYSE: ITW ) has good growth prospects, driven by its efficient use of R&D towards creating tailored solutions for its customers through its Customer-Back Innovation (CBI) initiative. In addition to gaining market share and helping volumes, CBI should Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.